A pilot study to investigate adherence to long-acting opioids among patients with advanced lung cancer.
A pilot study to investigate adherence to long-acting opioids among patients with advanced lung cancer.
复制标题
一项初步研究旨在调查晚期肺癌患者对长效阿片类药物的依从性。
DOI:
--
复制
发表时间:
2013
影响因子:
2.8
通讯作者:
J. Temel
中科院分区:
文献类型:
--
作者:
J. Yoong;L. Traeger;E. Gallagher;W. Pirl;J. Greer;J. Temel
BACKGROUND
Uncontrolled pain remains prevalent in patients with advanced cancer and has been associated with worse quality of life and greater health care utilization. Poor adherence to analgesics may represent a modifiable barrier to pain management.
OBJECTIVE
This pilot study aimed to establish feasibility/utility of evaluating self-reported adherence to long-acting (LA) opioids in patients with advanced lung cancer, and to explore rates and correlates of adherence.
METHODS
Consecutive patients attending an ambulatory thoracic oncology clinic with a diagnosis of advanced lung cancer and a current LA opioid regimen were approached to complete a brief questionnaire during their clinic visit. Participants reported LA opioid adherence during the past 4 weeks (0%-100%) and knowledge of their LA opioid regimen, and completed the Patient Health Questionnaire-2 (PHQ-2) depression screen. Demographic and clinical information were confirmed via electronic health record review.
RESULTS
Fifty-four eligible patients were approached to reach our target sample (n=50; enrollment=92.6%). Self-reported adherence to LA opioids was 85.4% (standard deviation [SD]=21.0). Twenty-eight percent reported a frequency of medication use that did not match the prescribed daily frequency. Lower adherence was associated with inaccurate frequency (p=0.004), positive depression screen (p=0.005), and older age (p=0.04).
CONCLUSIONS
Our results demonstrate the feasibility of integrating self-report assessments of LA opioid adherence into a thoracic oncology clinic. Patients reported high adherence, but more than one-quarter did not accurately report the prescribed frequency of daily doses. Understanding of LA opioid regimens may be a critical indicator of adherence in patients with advanced cancer.
影响因子:
4.7
作者:
Sun,VirginiaChih-Yi;Borneman,Tami;Ferrell,Betty;Piper,Barbara;Koczywas,Marianna;Choi,Kyong
通讯作者:
Choi,Kyong
影响因子:
158.5
作者:
CLEELAND, CS;GONIN, R;PANDYA, KJ
通讯作者:
PANDYA, KJ